XML 17 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
Total
Preferred Stock - Series A [Member]
Preferred Stock - Series B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Noncontrolling Interests [Member]
Balance at Mar. 31, 2015 $ (990,184) $ 0 $ 0 $ 4,863 $ 16,517,985 $ (19,340,521) $ 1,827,489
Balance (in shares) at Mar. 31, 2015   0 0 4,863,389      
Net income (loss) (8,173,389) $ 0 $ 0 $ 0 0 (9,344,044) 1,170,655
Stock-based compensation expense 1,103,976 $ 0 $ 0 $ 0 1,103,976 0 0
Stock-based compensation expense (in shares)   0 0 0      
Issuance of common stock in acquisition 1,512,500 $ 0 $ 0 $ 275 1,512,225 0 0
Issuance of common stock in acquisition (in shares)   0 0 275,000      
Distributions to noncontrolling interest (702,642) $ 0 $ 0 $ 0 0 0 (702,642)
Reclassification of noncontrolling interest to notes receivable 414,716 0 0 0 0 0 414,716
Net adjustment from change in APS ownership interest (305,315) 0 0 0 (338,032) 0 32,717
Conversion of 9% notes to common stock 553,851 $ 0 $ 0 $ 138 553,713 0 0
Conversion of 9% notes to common stock (in shares)   0 0 138,463      
Conversion of 8% notes and warrants to common stock 3,060,000 $ 0 $ 0 $ 600 3,059,400 0 0
Conversion of 8% notes and warrants to common stock (in shares)   0 0 600,000      
Issuance of preferred stock and equity warrant 4,999,995 $ 0 $ 3,884,745 $ 0 1,115,250 0 0
Issuance of preferred stock and equity warrant (in shares)   0 555,555 0      
Balance at Mar. 31, 2016 1,473,508 $ 0 $ 3,884,745 $ 5,876 23,524,517 (28,684,565) 2,742,935
Balance (in shares) at Mar. 31, 2016   0 555,555 5,876,852      
Net income (loss) (8,681,915)   $ 0 $ 0 0 (8,969,816) 287,901
Stock-based compensation expense 1,106,454 $ 0 $ 0 $ 0 1,106,454 0 0
Stock-based compensation expense (in shares)   0 0 0      
Issuance of common stock for exercise of warrants $ 172,000 $ 0 $ 0 $ 150 171,850 0 0
Issuance of common stock for exercise of warrants (in shares) 150,000 0 0 150,000      
Issuance of common stock for vested restricted stock $ 68 $ 0 $ 0 $ 7 61 0 0
Issuance of common stock for vested restricted stock (in shares)   0 0 6,666      
Relative fair value of warrants issued with debt 6,880 $ 0 $ 0 $ 0 6,880 0 0
Reclassification of Noncontrolling interest due to acquisition of VIE 0 0 0 0 183,408 0 (183,408)
Distributions to noncontrolling interest (1,200,000) 0 0 0 0 0 (1,200,000)
Conversion of 9% notes to common stock 0            
Deconsolidation of VIEs (1,023,183) 0 0 0 0 0 (1,023,183)
Warrants issuable for debt guarantee 161,000 0 0 0 161,000 0 0
Reclassification of mezzanine equity to permanent equity 7,077,778 $ 7,077,778 $ 0 $ 0 0 0 0
Reclassification of mezzanine equity to permanent equity (in shares)   1,111,111 0 0      
Reclassification of derivative liability to equity 1,177,778 $ 0 $ 0 $ 0 1,177,778 0 0
Balance at Mar. 31, 2017 $ 270,368 $ 7,077,778 $ 3,884,745 $ 6,033 $ 26,331,948 $ (37,654,381) $ 624,245
Balance (in shares) at Mar. 31, 2017   1,111,111 555,555 6,033,518